OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 118 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is 1.21 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $105,309 | +588.0% | 15,396 | +815.3% | 0.00% | – |
Q1 2024 | $15,306 | -64.8% | 1,682 | -82.8% | 0.00% | -100.0% |
Q4 2023 | $43,511 | +244.2% | 9,756 | +142.3% | 0.00% | – |
Q3 2023 | $12,642 | +3.8% | 4,026 | +70.6% | 0.00% | – |
Q2 2023 | $12,178 | +93576.9% | 2,360 | -6.6% | 0.00% | – |
Q1 2023 | $13 | -72.3% | 2,526 | -84.9% | 0.00% | -100.0% |
Q4 2022 | $47 | -99.8% | 16,685 | +135.2% | 0.00% | – |
Q3 2022 | $29,000 | +26.1% | 7,093 | +25.5% | 0.00% | -100.0% |
Q2 2022 | $23,000 | +228.6% | 5,651 | +297.1% | 0.00% | – |
Q1 2022 | $7,000 | -65.0% | 1,423 | -50.1% | 0.00% | – |
Q4 2021 | $20,000 | -54.5% | 2,852 | -36.2% | 0.00% | -100.0% |
Q3 2021 | $44,000 | -62.7% | 4,473 | -46.0% | 0.00% | -66.7% |
Q2 2021 | $118,000 | +68.6% | 8,282 | +94.8% | 0.00% | +200.0% |
Q1 2021 | $70,000 | -26.3% | 4,251 | -7.6% | 0.00% | -66.7% |
Q4 2020 | $95,000 | -78.2% | 4,602 | -92.0% | 0.00% | -40.0% |
Q3 2020 | $436,000 | +438.3% | 57,289 | +492.2% | 0.01% | +66.7% |
Q2 2020 | $81,000 | +710.0% | 9,674 | +362.4% | 0.00% | +200.0% |
Q1 2020 | $10,000 | +400.0% | 2,092 | +189.3% | 0.00% | – |
Q3 2019 | $2,000 | -75.0% | 723 | -62.4% | 0.00% | -100.0% |
Q2 2019 | $8,000 | -85.7% | 1,921 | -86.4% | 0.00% | -66.7% |
Q1 2019 | $56,000 | +47.4% | 14,108 | +48.3% | 0.00% | 0.0% |
Q4 2018 | $38,000 | +850.0% | 9,511 | +1506.6% | 0.00% | – |
Q3 2018 | $4,000 | -78.9% | 592 | -79.1% | 0.00% | -100.0% |
Q2 2018 | $19,000 | +375.0% | 2,839 | +392.0% | 0.00% | – |
Q1 2018 | $4,000 | -86.7% | 577 | -91.4% | 0.00% | -100.0% |
Q4 2017 | $30,000 | -9.1% | 6,720 | +27.4% | 0.00% | +33.3% |
Q3 2017 | $33,000 | +266.7% | 5,275 | +277.6% | 0.00% | +200.0% |
Q3 2016 | $9,000 | -35.7% | 1,397 | -51.9% | 0.00% | 0.0% |
Q2 2016 | $14,000 | +40.0% | 2,905 | +183.1% | 0.00% | -50.0% |
Q4 2015 | $10,000 | -52.4% | 1,026 | +101.6% | 0.00% | -33.3% |
Q1 2015 | $21,000 | – | 509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |